CN Stock MarketDetailed Quotes

688266 Suzhou Zelgen Biopharmaceuticals

Watchlist
  • 62.07
  • +1.43+2.36%
Trading Jan 7 13:43 CST
16.43BMarket Cap-94.19P/E (TTM)

Suzhou Zelgen Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Suzhou Zelgen Biopharmaceuticals Q3 2024 Earnings Date

Currency：CNYOct 26, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
143.42M
--
+130.67%
EPS
--
-0.12
--
--
Analyst Rating
Strong Buy

Jan 7, 2025

Suzhou Zelgen Biopharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.221B--
--2024/FY-- / 600.000M--
--2023/FY386.439M / 429.000M--
--2021/FY190.361M / 208.000M--
--2020/FY27.661M / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 1.221B--
--2024/FY-- / 600.000M--
--2023/FY386.439M / 429.000M--
--2021/FY190.361M / 208.000M--
--2020/FY27.661M / 0.000--

Unlock Free Earnings Estimates

Suzhou Zelgen Biopharmaceuticals Earnings Reports

  • Zejing Pharmaceutical Report for the Third Quarter of 2024

    Oct 25, 2024 12:00 ET

  • ZeJing Pharmaceutical's 2024 interim report

    Aug 23, 2024 12:00 ET

  • Summary of Zejing Pharmaceuticals' semi-annual report for 2024

    Aug 23, 2024 12:00 ET

  • Zejing Pharmaceutical 2023 Annual Report

    Apr 19, 2024 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    CHANGFU CO.,LTD
    871396
    19.00 +24.10%
    Ji Yao Holding Group
    300108
    0.95 +20.25%
    Hangzhou Huasu Technology
    301157
    58.54 +20.01%
    Jiusheng Electric
    301082
    14.76 +20.00%
    Zhejiang Chunhui Intelligent Control
    300943
    13.80 +20.00%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Jan 7, 2025

    Strong Buy

    • Strong Buy

      86.67%

    • Buy

      13.33%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data